Android app on Google Play

Piper Jaffray Starts Avanir Pharmaceuticals (AVNR) at Overweight

January 3, 2013 4:48 PM EST Send to a Friend
Get Alerts AVNR Hot Sheet
Price: $5.66 -1.22%

Rating Summary:
    5 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 10 | Down: 9 | New: 11
Trade AVNR Now!
Join SI Premium – FREE
Piper Jaffray initiates coverage on Avanir Pharmaceuticals (NASDAQ: AVNR) with a Overweight. PT $6.00.

For an analyst ratings summary and ratings history on Avanir Pharmaceuticals click here. For more ratings news on Avanir Pharmaceuticals click here.

Shares of Avanir Pharmaceuticals closed at $2.81 yesterday.

You May Also Be Interested In

Related Categories

New Coverage

Related Entities

Piper Jaffray

Add Your Comment